University of California San Francisco
Give to UCSF
In the most comprehensive study of the Mexican population to date, researchers from UCSF and Stanford University, along with Mexico’s National Institute of Genomic Medicine, have identified tremendous genetic diversity.
A team of researchers studying a flowering plant has zeroed in on the way cells manage external signals to adapt to prevailing conditions, a capability that is essential for cells to survive in a fluctuating environment.
Joshua Osborn was fighting for his life against a mysterious ailment. With his options dwindling, a team at UCSF employed advanced DNA sequencing technology to track down the culprit.
New genomic research led by UCSF scientists reveals that two common gene variants that lead to longer telomeres also significantly increase the risk of developing the deadly brain cancers known as gliomas.
Infants exposed to a diverse range of bacterial species in house dust during the first year of life appear to be less likely to develop asthma in early childhood, according to a new study conducted by UCSF researchers.
The calorie-burning triggered by cold temperatures can be achieved biochemically – without the chill – raising hopes for a weight-loss strategy focused on the immune system rather than the brain, according to a new UCSF study.
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
Research led by a UCSF investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.
University of California President Janet Napolitano and Nobel laureate Stanley Prusiner will be among several UC participants in the New York Times Health for Tomorrow conference, which will be webcast live.
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
Scientists and physicians at UCSF are leading a $26 million, multi-institutional research program to better understand and treat a range of common, debilitating psychiatric disorders.
UCSF's Peter Walter has received Asia’s highest scientific honor, the 2014 Shaw Prize in Life Science and Medicine, for his groundbreaking discovery of a cellular system that makes “life and death decisions” for the cell.
UCSF cell biologist Torsten Wittmann, PhD, has just made a key discovery of a molecular process that is a lynchpin in permitting the directional movement of cells.
Researchers at UCSF, UC Berkeley and partner institutions are receiving $6 million to help address three neglected tropical diseases that place a huge health and economic burden on people in Central and South America: Chagas’ disease, dengue and onchocerciasis.
Researchers from UCSF played major roles in five significant multicenter studies of lung disease published in The New England Journal of Medicine.
Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
As UC San Francisco marks 150 years as a medical college, it looks ahead to leading the next revolutions in health, education and science.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
The Food and Drug Administration has selected UCSF as the site of a new regulatory science center on the West Coast. The center aims to spur innovative approaches in drug development that will support the FDA’s ability to evaluate and approve safe and effective new medications.
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, according to a new study by a research team led by UC San Francisco and Harvard researchers.
New research out of UCSF is the first to demonstrate that highly stressed people who eat a lot of high-fat, high-sugar food are more prone to health risks than low-stress people who eat the same amount.
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as “astrocytes,” because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UCSF researchers.